Patent · US Active

Engineered Fc constructs

US11827682B2 · kind B2 · utility

0Cited by
15References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 16, 2021
Grant dateNov 28, 2023
Priority date—
Expiry dateNov 16, 2041

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure relates to engineered IgG Fc constructs and uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.